Sponsor Overview
Explore verified public information about Children's Hospital Los Angeles's expanded access programs, compassionate use policies, and patient eligibility pathways. This report aggregates official statements, independent research, and regulatory data to help patients, providers, and sponsors collaborate efficiently.
Unique references curated across 3 content categories.
ClinicalTrials.gov data sources power this status.
Dataset refreshed continuously through Right2Hope ETL pipelines.
Expanded Access Intelligence
Official Statements
Score contribution: 100 — 2 supporting sources.
“Use this simplified assent form template for Single Patient Expanded Access only. Please refer to the Expanded Access and Emergency Use of a Test Article (Drugs, Biologics and Devices) guidance available on the HSPP website at [https://www.chla.org/research/hspp](https://www.chla.org/research/hspp) for information on single patient expanded access.”
“Use this consent template for Single Patient Expanded Access only. Please refer to the Expanded Access and Emergency Use of a Test Article (Drugs, Biologics and Devices) guidance available on the HSPP website at [https://www.chla.org/research/hspp](https://www.chla.org/research/hspp) for information on single patient expanded access.”
Past EAPs on ClinicalTrials.gov
Score contribution: 40 — 1 supporting sources.
Conditions: Retinopathy of Prematurity
Partner with Right2Hope
Right2Hope helps sponsors translate regulatory programs into actionable patient access pathways. Connect with our team to publish new programs, streamline intake workflows, or align with providers seeking compassionate use options.